| 14. Stockholders' Equity |
14. Stockholders’ Equity Common Stock For the nine-month period ended November 30, 2022 | | Number of shares | | | Amount | | Balance, February 28, 2022 | | | 47,388,056 | | | $ | 4,740 | | Issuance of shares upon settlement of restricted stock units | | | 51,531 | | | | 5 | | Balance, November 30, 2022 | | | 47,439,587 | | | $ | 4,745 | |
For the nine-month period ended November 30, 2021 | | Number of shares | | | Amount | | Balance, February 28, 2021 | | | 42,413,691 | | | $ | 4,242 | | Issuance of shares upon settlement of restricted stock units | | | 231,660 | | | | 24 | | Issuance of shares for cash | | | 4,714,813 | | | | 471 | | Issuance of shares upon exercise of warrants | | | 11,666 | | | | 1 | | Issuance of shares upon exercise of options | | | 16,226 | | | | 2 | | Balance, November 30, 2021 | | | 47,388,056 | | | $ | 4,740 | |
During the nine-month period ended November 30, 2022, the Company recorded the following common stock transaction: (i) | The Company issued 51,531 shares of the common stock to settle restricted stock units that vested in the period. |
During the nine-month period ended November 30, 2021, the Company recorded the following common stock transactions: (i) | The Company issued 231,660 shares of the common stock to settle restricted stock units that vested in the period. | (ii) | The Company issued 4,714,813 shares of its common stock, with warrants, at an aggregate offering price of $12.00 per share for total gross proceeds of $56,577,756 and net proceeds of $56,084,304. | (iii) | The Company issued 11,666 shares of its common stock upon the exercise of a warrant. | (iv) | The Company issued 16,226 shares of its common stock upon the exercise of stock options. |
|